Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infectious Disease 2019 (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Not applicableStudy completedNCT04371315
What this trial is testing

Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children

Who this might be right for
Corona Virus InfectionPediatric CancerAdult Children+1 more
St. Jude Children's Research Hospital 33
Testing effectiveness (Phase 2)UnknownNCT04854928
What this trial is testing

Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.

Who this might be right for
COVID-19
Pharma Holdings AS 60
Not applicableStudy completedNCT04894409
What this trial is testing

Evaluation of Silver Nanoparticles for the Prevention of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Cluster de Bioeconomia de Baja California, A.C 231
Testing effectiveness (Phase 2)Study completedNCT06305793
What this trial is testing

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Who this might be right for
Long COVIDLong Coronavirus Disease 2019 (Covid19)Long Covid-19
Kanecia Obie Zimmerman 200
Not applicableStudy completedNCT04398264
What this trial is testing

Characteristics of COVID-19 Infection Among PREGnant Women

Who this might be right for
Corona Virus InfectionPregnancy Related
Inova Health Care Services 650
Not applicableUnknownNCT04452942
What this trial is testing

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
EicOsis Human Health Inc. 30
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Testing effectiveness (Phase 2)Ended earlyNCT04778059
What this trial is testing

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

Who this might be right for
2019 Novel Coronavirus InfectionCOVID-19 Virus InfectionSARS Coronavirus 2 Infection+3 more
US Biotest, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Testing effectiveness (Phase 2)Study completedNCT04478071
What this trial is testing

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirus Infection
The University of Texas Health Science Center, Houston 448
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Not applicableWithdrawnNCT04251767
What this trial is testing

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

Who this might be right for
COVID-19 Complicated With Refractory Intestinal Infections
The Second Hospital of Nanjing Medical University
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Large-scale testing (Phase 3)UnknownNCT05187793
What this trial is testing

Study of Efficacy of Different Treatment Regimens of Olokizumab

Who this might be right for
COVID-19
R-Pharm 198
Large-scale testing (Phase 3)Ended earlyNCT04508023
What this trial is testing

Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Janssen Research & Development, LLC 1,284
Testing effectiveness (Phase 2)Ended earlyNCT04899232
What this trial is testing

Antithrombin III in Infectious Disease Caused by COVID-19

Who this might be right for
Antithrombin III DeficiencyCovid19
Enrique Ginzburg 52
Next Page